Occupational Lung Disease Flashcards

1
Q

Diseases encompassed

A

Occupational asthma
COPD

Pneumoconioses (mineral dust)

  • Coal Workers’ Lung
  • Asbestosis
  • Silicosis

Malignant diseases
Lung cancer, Mesothelioma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Occupational history

A
Detailed history of exposure
Type of material
Duration 
Intensity
Temporal relationship to onset of symptoms

Symptoms - Improvement away from workplace

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pneumoconioses

A

Coal-workers’ pneumoconiosis
140 deaths/yr
Geography UK coalfields

Uncomplicated CWP – mild disease

Progressive Massive Fibrosis
Activation of alveolar macrophages
Progressive scarring causing stiff lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Silicosis

A

10-20 deaths/yr

Fibrotic lung disease

- Activation of macrophages	
- Restrictive lung function deficit 
- Eggshell calcification of lymph nodes

Risk factor for TB & lung cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Treatment of Pneumoconioses

A

Prevent further exposure
Stop smoking
Monitor lung function

Symptomatic treatment
Cough, dyspnoea, cor pulmonale

No cure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Asbestos - Benign

A

Pleural plaques (marker of exposure)
Benign pleural effusion
Pleural thickening & restriction
Asbestosis (fibrosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Asbestos - Malignant

A
Lung cancer
In asbestosis RR of lung cancer:
	7x in non-smokers
	93x in smokers
Mesothelioma
Malignancy of pleura and peritoneum
Expected to peak in 2020
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
Diagnosis of 
Occupational Asthma (OA
A

Occupational asthma that is caused by workplace exposures

OR

Work-aggravated asthma in which pre-existing cases are made worse by factors in the workplace

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Workplace factors

A
Recognition of high risk job
Co-workers similarly affected
Recent changes 
Products used, tasks undertaken
Preventative measures
Ventilation, masks etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Importance of Challenge Testing

A

Confirm diagnosis when new agent blamed

Identify responsible agent when multiple sensitisers in workplace

Confirm diagnosis when history & PEFR records are equivocal

(rarely) to exclude diagnosis in patient who will otherwise lose their job

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Challenge Testing

A

Asthma should be stable
Withhold bronchodilators

A placebo exposure day is advisable

Equipment that delivers known concentration of suspected agent

Monitor spirometry for several hours after each increase in exposure dose
May take several days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Allergic OA - High Molecular Weight

A

Proteins, polysaccharides
80-90% cases
Sensitisation with latency period (weeks-years)

IgE-dependent

Skin prick/allergy testing
Flour (bakers)
Animals (farmers)
Latex
Enzymes (eg detergents)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Allergic OA - Low Molecular Weight

A

Mechanism poorly understood
Usually independent of IgE

Limited utility of skin prick/allergy testing
Isocyanates (printing, plastics)
Metals (welders)
Dyes (hairdressers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Irritant-Induced/Non-Allergic Asthma

A

Direct effect on airways, not immune-mediated, occurs without pre-existing asthma

Acute
Reactive Airways Dysfunction Syndrome (RADS)
Develops within hours of a single, very high exposure to an irritant

Subacute
Insidious onset of asthma symptoms after multiple moderate/high exposure incidents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

RADS: some causative agents

A
Caustic vapours	
Ammonia		
Fire/Smoke
Chlorine 
Tear Gas	
Floor Sealants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pollutant

A

Any substance that contaminates the environment

17
Q

Toxin

A

A naturally occurring poison produced within living cells or organisms
Botulinum, Ricin, Snake venom

18
Q

Exposure & Toxins

A

Exposure is a function of:

  • Concentration of toxin/pollutant
  • Duration
  • Intensity (exercise etc)
  • Route (skin vs inhaled)
  • Metabolism of toxin

Clinical impact varies with individual susceptibility / comorbidity

19
Q

Toxin susceptibility

A

Genetic factors
eg protective effect of HbS against falciparum malaria

Co-morbidity / underlying diseases that augment clinical impact of toxic load

Environmental factors
Heat waves, cold snaps, smogs

20
Q

Vehicle Exhaust Pollutants

A
Primary pollutants
From fossil fuel combustion	
Nitrogen oxide
Sulphur dioxide (diesel)
Carbon monoxide
Particulate matter 
Fine particles of soot and metals forming smog

Secondary pollutants
From reactions between pollutants in the astmosphere

21
Q

NO

A

No effect on lung function in normals
Augments response to inhaled allergens
Increases likelihood that URTI will cause wheezing in children

22
Q

NO2 and infection

A
87 volunteers
exposure to 1-2 ppm, 2h/d, 3 days
intranasal challenge with influenza A virus on day 2 
91% infection in those exposed to NO2
71% in control subjects
23
Q

Health Effects of Ground Level Ozone

A

Decrease lung function
pro-inflammatory effects
- Increase cytokines (IL-6, IL-8, GM-CSF)
- neutrophilic bronchitis

Increase response to inhaled allergens
Increase respiratory morbidity

24
Q

Particulate Matter (PM) & Asthma

A

PM potentiates risk of airborne allergens causing atopic sensitisation

PM affects airway structural elements
Airway cilia
Mucous production
Oxidative stress to cell DNA
Induction of epithelial apoptosis

PM promotes airway inflammation and ↑ IgE production

25
Q

Exposure reduction

A

Occupational
FFP masks
ventilation

Environmental
Air quality warnings
Remain indoors, close windows
Minimise duration/intensity of outdoor activities
?anti-oxidants